ZCMD on Nasdaq

Zhongchao Inc.

Zhongchao Inc. is an educational services company in the Cayman Islands, listed on Nasdaq (ZCMD).1

Price unavailable

Last updated Oct 20, 2026.

Overview

$11.4MRevenue, fiscal 20252
-$6.3MNet income, fiscal 20252

Compare with Jianzhi Education Technology Group Co Ltd, Ambow Education Holding Ltd. or EpicQuest Education Group International Ltd, or pick any stock.

  • TickerZCMD on Nasdaq1
  • IndustryServices-Educational Services1
  • HeadquartersE91
  • Incorporated inCayman Islands3
  • Business addressRoom 2504, Oocl Tower, 841 Yan'An Middle Road, Jing'An District, Shanghai, 2000403
  • Filer categoryNon-accelerated filer3

Technology Limited, or Zhongchao WFOE, which was established on May 29, 2019 under the laws of the PRC.4 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

45.0%Gross margin2
-54.4%Operating margin2
-55.5%Net margin2
-28.3%Revenue growth, 20252
-33.9%Return on equity2

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Products and services

Medical Training And Education Services brought in 60% of the revenue Zhongchao Inc. broke down this way in fiscal 2025.

  1. Medical Training And Education Services$6.9M260%down 11% from 2024
  2. Patient Management Services In Patientaid Projects$3.8M234%down 36% from 2024
  3. Sales Of Patented Drugs$696.4K26%down 68% from 2024
Products and services by year
Products and services202320242025
Medical Training And Education Services$6.4M$7.7M$6.9M
Patient Management Services In Patientaid Projects$4.0M$6.0M$3.8M
Sales Of Patented Drugs$9.0M$2.2M$696.4K

Business segments

MDMOOCServices brought in 94% of the revenue Zhongchao Inc. broke down this way in fiscal 2025.

  1. MDMOOCServices$10.7M294%down 22% from 2024
  2. Sales Of Patented Drugs$696.4K26%down 68% from 2024
Business segments by year
Business segments202320242025
MDMOOCServices$10.4M$13.7M$10.7M
Sales Of Patented Drugs$9.0M$2.2M$696.4K

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Cost of revenue55¢$6.3M
  • Research and development0¢$8.1K
  • Other costs45¢$5.1M
  • Income tax0¢$46.2K

Out of $11.4M in revenue.2 The company lost money this year.

Where each dollar of operating cash went, fiscal 2025

  • Kept or used elsewhere100¢$845.4K

Out of $845.4K of cash from operations.2

Financial statements

Revenue567892$11.4M in 2025−12% since 2018
0$5.0M$10.0M$15.0M$20.0M2018: $12.9M$12.9M20182019: $14.9M$14.9M2019+16%2020: $18.0M$18.0M2020+21%2021: $16.3M$16.3M2021−9%2022: $14.2M$14.2M2022−13%2023: $19.4M$19.4M2023+37%2024: $15.9M$15.9M2024−18%2025: $11.4M$11.4M2025−28%
Gross profit567892$5.1M in 2025−39% since 2018
0$5.0M$10.0M$15.0M2018: $8.4M$8.4M20182019: $10.2M$10.2M2019+22%2020: $11.9M$11.9M2020+16%2021: $9.4M$9.4M2021−20%2022: $6.4M$6.4M2022−33%2023: $8.5M$8.5M2023+34%2024: $8.9M$8.9M2024+5%2025: $5.1M$5.1M2025−43%
Operating income67892-$6.2M in 2025
-$15.0M-$10.0M-$5.0M0$5.0M2019: $3.6M$3.6M20192020: $4.5M$4.5M2020+23%2021: -$320.7K-$320.7K20212022: -$3.0M-$3.0M2022+821%2023: -$13.3M-$13.3M2023+350%2024: -$341.3K-$341.3K2024−97%2025: -$6.2M-$6.2M2025+1714%
Net income5892-$6.3M in 2025
-$15.0M-$10.0M-$5.0M0$5.0M2018: $3.0M$3.0M20182019: $4.0M$4.0M2019+34%2020: $4.5M$4.5M2020+10%2021: $238.7K$238.7K2021−95%2022: -$2.9M-$2.9M20222023: -$11.3M-$11.3M2023+285%2024: -$643.2K-$643.2K2024−94%2025: -$6.3M-$6.3M2025+881%

Every line of the income statement as filed: the last 3 fiscal years, latest first.2

Period ending2025-12-312024-12-312023-12-31
Total revenues$11.4M$15.9M$19.4M
Total cost of revenues-$6.3M-$7.0M-$10.9M
Gross Profit$5.1M$8.9M$8.5M
Selling and marketing expenses-$1.5M-$4.0M-$6.7M
General and administrative expenses-$9.8M-$5.0M-$6.7M
Research and development expenses-$8.1K-$252.5K-$514.4K
Loss from disposal of property and equipment-$1.7M
Impairment of goodwill-$5.6M
Impairment of intangible assets-$536.2K
Total Operating Expenses-$11.3M-$9.3M-$21.8M
Loss from Operations-$6.2M-$341.3K-$13.3M
Interest income, net$343.1K$243.0K$237.1K
Other income, net$79.4K$160.0K$1.1M
(Loss) Income Before Income Taxes-$5.8M$61.8K-$12.0M
Income tax (expenses) benefits-$46.2K-$335.2K$669.8K
Net Loss-$5.8M-$273.4K-$11.3M
Net loss attributable to noncontrolling interests-$495.3K-$369.8K-$28.7K
Net Loss Attributable to Zhongchao Inc.s shareholders-$6.3M-$643.2K-$11.3M
Foreign currency translation adjustment$556.4K-$561.6K-$809.4K
Comprehensive Loss-$5.3M-$835.0K-$12.1M
Total comprehensive (loss) income attributable to noncontrolling interests-$654.1K-$281.8K$59.7K
Total Comprehensive Loss Attributable to Zhongchao Inc.s Shareholders-$5.9M-$1.1M-$12.1M
Weighted Average Number of Ordinary Share Outstanding Basic (in Shares)3.4M shares650.7K shares325.4K shares
Weighted Average Number of Ordinary Share Outstanding Diluted (in Shares)3.4M shares650.7K shares325.4K shares
Loss per Share Basic (in Dollars per share)-$1.85-$0.99-$34.83
Loss per Share Diluted (in Dollars per share)-$1.85-$0.99-$34.83

Compare Zhongchao Inc. with another company

Corporate structure

Zhongchao Inc. sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Zhongchao Inc.

  • S.H.N. Financial Investments Ltd. Filed SCHEDULE 13G/A on Zhongchao Inc., latest Aug 14, 2026 (2 filings since Jun 5, 2026)
  • Weiguang Yang Filed SCHEDULE 13D/A on Zhongchao Inc., latest Jul 22, 2026 (2 filings since Aug 27, 2025)
  • Zhongchao Inc. E9

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Zhongchao Inc. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Accumulated depreciation$675.7K2 Dec 31, 2025$400.6K2 Dec 31, 2024+68.7%
Property and equipment, net$5.9M2 Dec 31, 2025$5.9M2 Dec 31, 2024+0.2%
Operating-lease assets (leased space)$25.1K2 Dec 31, 2025$89.0K2 Dec 31, 2024−71.9%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$8.1M2 Dec 31, 2025$7.8M2 Dec 31, 2024+3.3%
Marketable securities, current$5.8M2 Dec 31, 2025$5.2M2 Dec 31, 2024+11.1%
Marketable securities, non-current$1.2M2 Dec 31, 2025$1.1M2 Dec 31, 2024+12.9%
Stakes in other companies (equity method)$1.1M2 Dec 31, 2025$1.1M2 Dec 31, 2024+4.3%

Intangibles and goodwill

ItemLatestA year beforeChange
Intangible assets, net (excluding goodwill)$7.6K2 Dec 31, 2025$12.2K2 Dec 31, 2024−37.5%
Accumulated amortization$44.3K2 Dec 31, 2025$37.5K2 Dec 31, 2024+18.0%
Finite-lived intangibles, net$7.6K2 Dec 31, 2025$12.2K2 Dec 31, 2024−37.5%

Inventory

ItemLatestA year beforeChange
Inventory, total$586.2K2 Dec 31, 2024$592.4K9 Dec 31, 2023−1.0%

Leadership

Who has led Zhongchao Inc., and when. Pick a name to see everywhere that person has worked.

Board members and other officers (2)

Filings

89 filings to the SEC since October 2021: 6 annual reports, 6 insider forms, 4 large holders, 73 other. The latest 20:

  1. Sep 21, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  2. Sep 11, 20266-K CURRENT REPORT EDGAR
  3. Aug 14, 2026SCHEDULE 13G/A EDGAR
  4. Aug 11, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  5. Aug 6, 2026424B5 PROSPECTUS SUPPLEMENT EDGAR
  6. Jul 28, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  7. Jul 24, 2026424B5 PROSPECTUS SUPPLEMENT EDGAR
  8. Jul 22, 2026SCHEDULE 13D/A EDGAR
  9. Jul 22, 20264 EDGAR
  10. Jul 22, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  11. Jun 23, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  12. Jun 9, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  13. Jun 9, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  14. Jun 5, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  15. Jun 5, 2026SCHEDULE 13G EDGAR
  16. Jun 1, 2026424B4 PROSPECTUS EDGAR
  17. May 28, 2026EFFECT EDGAR
  18. May 26, 2026CORRESP EDGAR
  19. May 26, 2026CORRESP EDGAR
  20. May 22, 2026F-1/A AMENDMENT NO. 1 TO FORM F-1 EDGAR

The 89 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

SEC filer profile

How Zhongchao Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARZhongchao Inc.1
  • CIK0001785566
  • Filer statusNon-accelerated filer not an emerging growth company; not a shell company4
  • Incorporated inCayman Islands4
  • Fiscal year endsDecember 311
  • Industry code (SIC)8200 Services-Educational Services1
  • SEC reviewing officeOffice of Trade & Services, Division of Corporation Finance1
  • Business addressRoom 2504, Oocl Tower, 841 Yan'An Middle Road, Jing'An District, Shanghai, 200040, China1
  • Phone021-322059871
  • Shares outstanding3,236,141 Common Class A shares; 624,972 Common Class B shares as of Dec 31, 20254
  • AuditorPrager Metis CPAs, LLC, Hackensack, New Jersey PCAOB ID 273; no auditor attestation of internal control over financial reporting4
  • On EDGAR sinceAug 19, 20191
  • Filings154 in all: 6-K (62), CORRESP (18), UPLOAD (13), 20-F (7), 3 (5), EFFECT (5), F-1/A (5), 424B5 (4)1
    All 30 form types

    F-3 (3), F-3/A (3), NT 20-F (3), 20-F/A (2), DRS (2), DRS/A (2), DRSLTR (2), F-1 (2), S-8 (2), SCHEDULE 13D/A (2), 4 (1), 424B1 (1), 424B4 (1), 8-A12B (1), CERT (1), FWP (1), RW (1), RW WD (1), SC 13D (1), SC 13D/A (1), SCHEDULE 13G (1), SCHEDULE 13G/A (1)

  • Latest filingsAnnual report (20-F) Apr 3, 2026

Securities registered for trading

ClassSymbolExchange
Class A Ordinary shares, par value $0.008The Nasdaq Stock Market LLC

From the cover page of the 20-F filed Apr 3, 2026 (Section 12(b) of the Exchange Act).4